Vonapanitase: Ph III PATENCY-1 data
Top-line data from the double-blind, U.S. Phase III PATENCY-1 trial in 313 CKD patients receiving or expecting hemodialysis who underwent surgical creation of a radiocephalic AVF showed that a single ...
BCIQ Company Profiles
BCIQ Target Profiles